What is the name of Vigabatrin (Okeda) and its trade name analysis?

Vigabatrin (Vigabatrin) is an anti-epileptic drug. Its scientific name is Vigabatrin, which is often translated as vigabatrin in Chinese, and "Vigabatrin" is one of its trade names in some markets. This type of drug mainly inhibits γ-aminobutyric acid (GABA) aminotransferase, thereby increasing the concentration of GABA in the brain, stabilizing neuron discharge and reducing epileptic seizures. Because this drug is an anti-epileptic drug with a special mechanism of action, it is usually used clinically for patients with refractory epilepsy, especially in cases where other common drugs are ineffective.

From a global perspective, the trade names of Vigabatrin are not uniform. In the United States and Europe, the common trade name is Sabril, which is also used in Canada, Australia and other places; while in Hong Kong, China and some areas, it is called Vigabatrin. Although these trade names are different, their drug ingredients and pharmacological mechanisms are exactly the same. When patients look up information or purchase medicines, they are often confused because of the difference in names. Therefore, it is particularly important to clarify the correspondence between the scientific name and the trade name.

It needs to be emphasized that Vigabatrin (such as Sabril, Vigabatrin, etc.) may have differences in packaging specifications and approved indications in different countries and regions. For example, in some countries the drug is approved for the treatment of infantile spasms (infantile spasms), while in others it is mainly used as an adjuvant treatment for refractory partial epilepsy. Therefore, patients must read the local instructions and doctor's advice before use, and cannot substitute or mix the products based on the product name alone.

In summary, Vigabatrin (Vigabatrin) is a common trade name of this drug in the Chinese context, and Sabril is its main registered trademark in Europe and the United States. No matter what name it is called, its core ingredient is Vigabatrin. When patients understand and use this drug, it is recommended that they first confirm the common name (scientific name) of the drug, and then combine it with the doctor's prescription and drug instructions to ensure safe and standardized medication.

Reference link:https://www.drugs.com